Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-11-25

Clinical Trial Update: Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study [NA]

View source ↗

Summary

A clinical trial evaluating radiofrequency ablation for uterine fibroids to reduce menstrual bleeding has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gynesonics | Conditions: Leiomyoma, Uterine Fibroids | NA | Status: WITHDRAWN